Delay in the diagnosis of melanoma was defined as the interval in months from the patient's report of first noticing a suspected lesion to the date of the removal of a histologically confirmed melanoma. 216 patients were included in our study. Total delay was subdivided in three components: patient, medical and referral delay. The major component of delay is due to the patient and the most important cause of it was lack of concern. Lesions in men were detected more frequently by family members, while in women melanomas tended to be self-detected. Nodular melanoma had lower delay but higher thickness. Amelanotic melanomas had a higher delay principally due to the physicians. A significative positive correlation between Breslow thickness and ...
Larger keratinocyte carcinoma (KC) lesions are associated with higher morbidity. This study examined...
62 patients with a histologically confirmed diagnosis of cutaneous malignant melanoma were interview...
INTRODUCTION AND AIM: Melanoma is a highly aggressive tumour with often unpredictable outcome. Our a...
Objectives. An important factor that influence survival of patients with melanoma is tumour thicknes...
Background: Patients and physicians both play an important role in the diagnosis of malignant melano...
The present study aimed to: (i) define thick melanomas related to nodular melanomas and other melano...
Copyright © 2014 Senada Hajdarevic et al. This is an open access article distributed under the Creat...
Eine frühe Diagnose und Therapie des kutanen malignen Melanoms bedarf sowohl der Mitarbeit des Patie...
Amelanotic melanomas (AM) are a difficult diagnostic challenge for clinicians. Objective To consider...
Objectives The principle aim of this paper is to explore the available evidence based literature ex...
Objective: To examine the relationship between melanoma thickness and reported time from first recog...
Background: The incidence of melanoma is rising. Early detection is associated with a more favourabl...
A) Time from initial consultation until patient informed on excision biopsy histopathology report (m...
Melanoma is an extremely aggressive cancer for which the American Academy of Dermatology currently d...
Diagnostic delay in a group of 189 women with breast cancer was studied and correlated with first sy...
Larger keratinocyte carcinoma (KC) lesions are associated with higher morbidity. This study examined...
62 patients with a histologically confirmed diagnosis of cutaneous malignant melanoma were interview...
INTRODUCTION AND AIM: Melanoma is a highly aggressive tumour with often unpredictable outcome. Our a...
Objectives. An important factor that influence survival of patients with melanoma is tumour thicknes...
Background: Patients and physicians both play an important role in the diagnosis of malignant melano...
The present study aimed to: (i) define thick melanomas related to nodular melanomas and other melano...
Copyright © 2014 Senada Hajdarevic et al. This is an open access article distributed under the Creat...
Eine frühe Diagnose und Therapie des kutanen malignen Melanoms bedarf sowohl der Mitarbeit des Patie...
Amelanotic melanomas (AM) are a difficult diagnostic challenge for clinicians. Objective To consider...
Objectives The principle aim of this paper is to explore the available evidence based literature ex...
Objective: To examine the relationship between melanoma thickness and reported time from first recog...
Background: The incidence of melanoma is rising. Early detection is associated with a more favourabl...
A) Time from initial consultation until patient informed on excision biopsy histopathology report (m...
Melanoma is an extremely aggressive cancer for which the American Academy of Dermatology currently d...
Diagnostic delay in a group of 189 women with breast cancer was studied and correlated with first sy...
Larger keratinocyte carcinoma (KC) lesions are associated with higher morbidity. This study examined...
62 patients with a histologically confirmed diagnosis of cutaneous malignant melanoma were interview...
INTRODUCTION AND AIM: Melanoma is a highly aggressive tumour with often unpredictable outcome. Our a...